ALEXIS KINCH: Open Payments
NPI 1932731338 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,787 in 90 payments from 18 companies in 2025. Trend: 2023 $413 · 2024 $1,153 · 2025 $1,787
Food & beverage: $1,787
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. | 7 | $271 |
| ACADIA Pharmaceuticals Inc | 7 | $248 |
| Neurocrine BioSciences, Inc. | 21 | $225 |
| Eisai Inc. | 8 | $189 |
| Amneal Pharmaceuticals LLC | 9 | $143 |
| Lilly USA, LLC | 6 | $106 |
| MDD US Operations, LLC | 6 | $106 |
| PFIZER INC. | 6 | $98 |
| ABBVIE INC. | 4 | $89 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $78 |
Products named: NUPLAZID, INGREZZA, Leqembi, CREXONT, Mavenclad, NURTEC ODT, AMYVID, HYQVIA.
Industry payments across OH — which companies pay providers there.
